Ana C Garrido-Castro, MD
2 clinical trials · Sponsor
◉ Watch Ana C Garrido-Castro, MD
| Record | Firm | Date |
|---|---|---|
| TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd (NCT06533826) | Ana C Garrido-Castro, MD | 2024-10-29 |
| Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC (NCT04448886) | Ana C Garrido-Castro, MD | 2020-09-23 |
Track Ana C Garrido-Castro, MD automatically
Every clearance here is in the API, with alerts when new ones post.